Literature DB >> 21339647

Crohn disease--associated adherent-invasive E. coli bacteria target mouse and human Peyer's patches via long polar fimbriae.

Benoit Chassaing1, Nathalie Rolhion, Amélie de Vallée, Sa'ad Y Salim, Maelle Prorok-Hamon, Christel Neut, Barry J Campbell, Johan D Söderholm, Jean-Pierre Hugot, Jean-Frédéric Colombel, Arlette Darfeuille-Michaud.   

Abstract

Crohn disease (CD) is a multifactorial disease in which an abnormal immune response in the gastrointestinal (GI) tract leads to chronic inflammation. The small intestine, particularly the ileum, of patients with CD is colonized by adherent-invasive E. coli (AIEC)--a pathogenic group of E. coli able to adhere to and invade intestinal epithelial cells. As the earliest inflammatory lesions are microscopic erosions of the epithelium lining the Peyer's patches (PPs), we investigated the ability of AIEC bacteria to interact with PPs and the virulence factors involved. We found that AIEC bacteria could interact with mouse and human PPs via long polar fimbriae (LPF). An LPF-negative AIEC mutant was highly impaired in its ability to interact with mouse and human PPs and to translocate across monolayers of M cells, specialized epithelial cells at the surface of PPs. The prevalence of AIEC strains harboring the lpf operon was markedly higher in CD patients compared with controls. In addition, increased numbers of AIEC, but not LPF-deficient AIEC, bacteria were found interacting with PPs from Nod2(-/-) mice compared with WT mice. In conclusion, we have identified LPF as a key factor for AIEC to target PPs. This could be the missing link between AIEC colonization and the presence of early lesions in the PPs of CD patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21339647      PMCID: PMC3049390          DOI: 10.1172/JCI44632

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

1.  Infection of rabbit Peyer's patches by Shigella flexneri: effect of adhesive or invasive bacterial phenotypes on follicle-associated epithelium.

Authors:  P J Sansonetti; J Arondel; J R Cantey; M C Prévost; M Huerre
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease.

Authors:  J Boudeau; A L Glasser; E Masseret; B Joly; A Darfeuille-Michaud
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  The role of Peyer's patches in the age-related incidence of Crohn's disease.

Authors:  H J Van Kruiningen; L M Ganley; B J Freda
Journal:  J Clin Gastroenterol       Date:  1997-09       Impact factor: 3.062

4.  Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria.

Authors:  S Kernéis; A Bogdanova; J P Kraehenbuhl; E Pringault
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

5.  Invasin-dependent and invasin-independent pathways for translocation of Yersinia pseudotuberculosis across the Peyer's patch intestinal epithelium.

Authors:  A Marra; R R Isberg
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  Expression and transcriptional control of the Salmonella typhimurium Ipf fimbrial operon by phase variation.

Authors:  T L Norris; R A Kingsley; A J Bümler
Journal:  Mol Microbiol       Date:  1998-07       Impact factor: 3.501

7.  Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease.

Authors:  A Darfeuille-Michaud; C Neut; N Barnich; E Lederman; P Di Martino; P Desreumaux; L Gambiez; B Joly; A Cortot; J F Colombel
Journal:  Gastroenterology       Date:  1998-12       Impact factor: 22.682

8.  Some properties of purified Escherichia coli heat-stable enterotoxin II.

Authors:  S Hitotsubashi; Y Fujii; H Yamanaka; K Okamoto
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

9.  The lpf fimbrial operon mediates adhesion of Salmonella typhimurium to murine Peyer's patches.

Authors:  A J Bäumler; R M Tsolis; F Heffron
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

10.  Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches.

Authors:  B D Jones; N Ghori; S Falkow
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  95 in total

Review 1.  Potential role of chitinases and chitin-binding proteins in host-microbial interactions during the development of intestinal inflammation.

Authors:  H T Tran; N Barnich; E Mizoguchi
Journal:  Histol Histopathol       Date:  2011-11       Impact factor: 2.303

Review 2.  IBD-what role do Proteobacteria play?

Authors:  Indrani Mukhopadhya; Richard Hansen; Emad M El-Omar; Georgina L Hold
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

3.  Analysis of the σE regulon in Crohn's disease-associated Escherichia coli revealed involvement of the waaWVL operon in biofilm formation.

Authors:  Benoit Chassaing; Estelle Garénaux; Jessica Carriere; Nathalie Rolhion; Yann Guérardel; Nicolas Barnich; Richard Bonnet; Arlette Darfeuille-Michaud
Journal:  J Bacteriol       Date:  2015-02-09       Impact factor: 3.490

Review 4.  NOD proteins: regulators of inflammation in health and disease.

Authors:  Dana J Philpott; Matthew T Sorbara; Susan J Robertson; Kenneth Croitoru; Stephen E Girardin
Journal:  Nat Rev Immunol       Date:  2013-12-13       Impact factor: 53.106

Review 5.  Impact of the gut microbiome on mucosal inflammation.

Authors:  Warren Strober
Journal:  Trends Immunol       Date:  2013-08-16       Impact factor: 16.687

Review 6.  New targets for mucosal healing and therapy in inflammatory bowel diseases.

Authors:  M F Neurath
Journal:  Mucosal Immunol       Date:  2013-10-02       Impact factor: 7.313

7.  Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome.

Authors:  Marjorie De la Fuente; Luigi Franchi; Daniela Araya; David Díaz-Jiménez; Mauricio Olivares; Manuel Álvarez-Lobos; Douglas Golenbock; María-Julieta González; Francisco López-Kostner; Rodrigo Quera; Gabriel Núñez; Roberto Vidal; Marcela A Hermoso
Journal:  Int J Med Microbiol       Date:  2014-02-06       Impact factor: 3.473

Review 8.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 9.  Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Bruce Andrew Vallance; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

Review 10.  The gut microbiota in IBD.

Authors:  Chaysavanh Manichanh; Natalia Borruel; Francesc Casellas; Francisco Guarner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-08-21       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.